3Terasaki PI. Deduction of the fraction of immunologic and non-im-munologic failure in cadaver donor transplants. Clinical Trans-plants,2003,449452.
4Mauiyyedi S,Crespo M,Collins AB,et al. Acute humoral rejectionin kidney transplantati- on: II Morphology, immunopathology andpathologic classification. J Am Soc Nephrol, 2002,13 (3 ) :779-787.
5Regele H. Non-HLA antibodies in kidney allograft rejection: con-vincing concept in need of further evidence. Kidney Int,2011,79(6) :583-586.
6Wang R,wang H,Chen J,et al. C4d deposition in allograft renalbiopsies is an independent risk fact for graft faiure. Nephrology(Carton) ,2009,14(5) :527-532.
7Zou Y, Stastny P. The role of major histocompatibility complexclass chain- related gene A antibodies in organ transplantation.Curr Opin Organ Transplant,2009,14(4) :414-418.
8Sun Q, Cheng Z,Cheng D, et al. De novo development of circu-lating anti-endothelial cell antibodies rather than pre-existinganti-bodies is associated with post-transplant allograft rejection. KidneyInt,2011 ,79(6) :655-662.
9Nakagawa Y,Saito K,Morioka T,et al. The clinical significanceof antibody to vascular endothelial cells after renal transplanta-tion. Clin Transplant ,2002,16 ( Suppl8) :51-57.
